Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPHE Hotel Group Limited Regulatory News (PPH)

Share Price Information for PPHE Hotel Group Limited (PPH)

Share Price is delayed by 15 minutes
Get Live Data
2,005.00    -45.00 (-2.20%)
Bid:
2,010.00
Ask:
2,050.00
Spread: 40.00 (1.99%)
Market Cap: £839.27m
PPH Live PriceLast checked at - London Stock Exchange

Intraday PPHE Hotel Group Limited Share Chart

Form 8.5 (EPT/RI) - PPHE Hotel Group Limited

1 Jun 2026 08:50

RNS Number : 4233G
Morgan Stanley & Co. LLC
01 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PPHE Hotel Group Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Fattal Hotel Group

(d) Date dealing undertaken:

29 May 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary NPV

PURCHASES

636

19.8900 GBP

19.8900 GBP

Ordinary NPV

SALES

636

19.8900 GBP

19.8900 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

01 June 2026

Contact name:

Claire Gordon

Telephone number:

+44 141 245-8893

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFIFSDRTILIIR
Date   Source Headline
8th Aug 20252:16 pmRNSArena Hospitality Notice of Leasehold Termination
4th Aug 20257:00 amRNSNotice of Interim Results
29th Jul 20257:21 amRNSPublication of Arena Interim Financial Report
23rd Jun 20257:00 amRNSAcquisition of development site
21st May 20255:51 pmRNSResult of AGM
8th May 20255:21 pmRNSTotal Voting Rights
8th May 202512:07 pmRNSIncrease in Arena Hospitality Group shareholding
30th Apr 20257:00 amRNSQ1 Trading Update
24th Apr 20257:00 amRNSPublication of Arena Q1 Interim Financial Report
24th Apr 20257:00 amRNSHolding(s) in Company
16th Apr 20257:00 amRNSNotice of Trading Update
2nd Apr 20259:41 amRNSHolding(s) in Company
27th Mar 20257:00 amRNSAGM Notice and Proposed Rule 9 Waiver
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20256:19 pmRNSGrant and exercise of EVP Annual Bonus Plan
27th Feb 20257:09 amRNSPublication of 2024 Arena Annual Report
27th Feb 20257:00 amRNSAnnual Results & Publication of Annual Report
19th Feb 20257:00 amRNS-RAnnual Results Investor Presentation
6th Feb 20257:00 amRNSNotice of Annual Results
28th Jan 20257:00 amRNSYear-end Trading Update
22nd Jan 20257:00 amRNSNotice of Trading Update
9th Jan 20255:37 pmRNSAppointment of Non-Executive Director
9th Jan 20251:10 pmRNSDirectorate Change
9th Dec 20247:00 amRNSFTSE EPRA Nareit Global Developed Index Inclusion
31st Oct 20247:00 amRNSPublication of Arena Q3 Interim Financial Report
31st Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSTransactions in own securities
15th Oct 20247:00 amRNSNotice of Results
15th Oct 20247:00 amRNSTransactions in own securities
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransactions in own securities
10th Oct 20247:00 amRNSTransactions in own securities
9th Oct 20247:00 amRNSTransactions in own securities
8th Oct 20247:00 amRNSTransactions in own securities
7th Oct 20247:00 amRNSTransactions in own securities
4th Oct 20247:00 amRNSTransactions in own securities
3rd Oct 20247:00 amRNSTransactions in own securities
2nd Oct 20247:00 amRNSTransactions in own securities
1st Oct 20247:00 amRNSTransactions in own securities
30th Sep 20247:00 amRNSTransactions in own securities
27th Sep 20247:00 amRNSTransactions in own securities
26th Sep 20247:00 amRNSTransactions in own securities
12th Sep 20245:14 pmRNSPDMR Notification
11th Sep 20247:00 amRNSTransactions in own securities
10th Sep 20247:00 amRNSTransactions in own securities
9th Sep 20247:00 amRNSTransactions in own securities
6th Sep 20247:00 amRNSTransactions in own securities
5th Sep 20247:00 amRNSTransactions in own securities
5th Sep 20247:00 amRNSMajor refinancing extending maturity to 2031
4th Sep 20247:00 amRNSTransaction in Own Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.